Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant
Published on: PR Newswire The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube Seegene
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC
Published on: PR Newswire Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in the Atlanta, GA, United States AIOS
Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus
Published on: PR Newswire Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for
Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic
Published on: PR Newswire Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month SEOUL, Korea (April 12, 2021)
Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
Published on: BUSINESS WIRE Real-time test differentiates influenza A & B, RSV and COVID-19 SEOUL, South Korea (March 1, 2021)— Seegene Inc., (KQ096530), a biotechnology
Seegene’s Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants
Published on: PR Newswire – Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min– Seegene’s proprietary high multiplex